Valion Bio, Inc.
VBIO
$1.10
-$0.01-0.90%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.99% | -16.90% | 6.06% | 25.40% | 31.40% |
| Total Depreciation and Amortization | -98.58% | 118.25% | 63.31% | 66.85% | 93.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.85% | 419.49% | 274.00% | 205.20% | 154.46% |
| Change in Net Operating Assets | 137.89% | -145.69% | -34.08% | 32.77% | -58.64% |
| Cash from Operations | -22.25% | 0.93% | 16.82% | 36.16% | 32.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -2,091.67% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -44.17% | 9.03% | -58.41% | 4.03% | -48.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -528.57% | 95.54% | -418.46% | 62.50% | -- |
| Cash from Financing | 323.52% | 150.29% | -53.81% | 4.65% | -49.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 864.03% | 142.32% | -342.65% | 71.45% | -1,041.80% |